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Abstract
Segmentation of both white matter lesions and deep grey matter structures is
an important task in the quantification of magnetic resonance imaging in mul-
tiple sclerosis. Typically these tasks are performed separately: in this paper we
present a single segmentation solution based on convolutional neural networks
(CNNs) for providing fast, reliable segmentations of multimodal magnetic reso-
nance images into lesion classes and normal-appearing grey- and white-matter
structures. We show substantial, statistically significant improvements in both
Dice coefficient and in lesion-wise specificity and sensitivity, compared to pre-
vious approaches, and agreement with individual human raters in the range of
human inter-rater variability. The method is trained on data gathered from a
single centre: nonetheless, it performs well on data from centres, scanners and
field-strengths not represented in the training dataset. A retrospective study
found that the classifier successfully identified lesions missed by the human
raters.
Lesion labels were provided by human raters, while weak labels for other
brain structures (including CSF, cortical grey matter, cortical white matter,
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cerebellum, amygdala, hippocampus, subcortical GM structures and choroid
plexus) were provided by Freesurfer 5.3. The segmentations of these struc-
tures compared well, not only with Freesurfer 5.3, but also with FSL-First and
Freesurfer 6.0.
Keywords: Deep Learning, Multiple Sclerosis, MRI
1. Introduction
MR-based imaging biomarkers are an integral part of the diagnosis and
follow-up of multiple sclerosis for more than 20 years [1]. During this time,
there has been a constant development of advanced methods to further improve
diagnostic accuracy, establish prognosis and outcome, and leverage clinical mon-
itoring of patients with MS. Established biomarkers for MS include baseline MRI
lesion count, temporal evolution of lesion load, including the formation of new
lesions, as well as the integrity of the blood brain barrier, signatures of axonal
damage, and atrophy of cortical and subcortical grey matter. These measures of
progression are routinely assessed by expert human readers. [2]. In the PRISMS
long-term follow up study in patients with remitting-relapsing MS, higher brain
volume at baseline was identified as a prognostic imaging markers for better
outcome and decreased likelihood to convert into secondary progressive multi-
ple sclerosis [3] . MRI volumes at baseline and T2-lesion burden have also been
found to correlate with disability outcomes in previous studies. [4, 5, 6]. Recent
evidence has suugested to monitor disease progression either by segmentation
and quantification of T2 lesion load (reflecting inflammatory disease activity) or
whole brain volume loss on T1-weighted images (reflecting ongoing neurodegen-
eration). Both measures are biomarkers for the prediction of disease progression
and the efficacy of disease modifying treatment regimens. Based on a survey on
the prospectively collected MSBase cohort on 8311 MRI scans with new lesions
during follow up, it could be demonstrated that treatment decisions rely mainly
on MRI monitoring and that subclinical T2 lesion progression was associated
with increased odds of treatment change, with every new T2 lesion increasing
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the odds ratio of treatment change within 12 months by 1.26 [7].
There is a considerable variance in lesion quantification between expert
readers with different backgrounds (e.g. neuroradiologists vs. neuroimmunolo-
gists), and also substantial intra-rater variation. [8] Automated methods are by
their nature repeatable, and an increasing number of publications have there-
fore investigated machine learning methods to solve the problem of unbiased
lesion quantification. A previous survey of MS lesion segmentation methods
showed that the majority of approaches were employing either Expectation-
Maximization or k-nearest-neighbours methods.[9] Unsupervised techniques such
as Expectation-Maximization and Maximum A Priori estimation remain well-
accepted methodologies for brain lesion segmentation.[10, 11] More recently,
improvements in hardware and software have enabled fast training and ap-
plication of deep convolutional neural networks (CNNs), leading to a num-
ber of deep-learning approaches to brain segmentation. CNN-based approaches
were the winning entries in several segmentation challenges over the last years.
[12, 13, 14]. The low availability of high quality training data annotated by ex-
pert raters means that transferability is of high importance: a classifier trained
on data from a single or small number of centers must be able to operate well
on data from centres and scanners not seen during training. It is often the case
that CNN-based methods do not have this property: performance is substan-
tially degraded on external data, with retraining on additional labelled data from
the external centre being required before good performance is reestablished.[15]
Valverde and coworkers (2018) analyzed the effect of domain adaptation on
their proposed CNN-based MS lesion segmentation method and investigated
the transferability of the CNN model when applied to other MRI scanners and
protocols, evaluating the minimum number of annotated images needed from
the new domain and the minimum number of layers needed to re-train to ob-
tain comparable accuracy. Performance without domain adaptation was sub-
stantially degraded. Domain adaptation was progressively more effective with
increasing training cases, but the models still yielded a remarkably high perfor-
mance on reduced training sets, such as a single training case.
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Deep learning has also been applied to the segmentation of healthy brains.
Initial attempts relied on the small numbers (30) of hand labelled brains, while
later attempts have leveraged the availability of large cohorts of imaging data
by training on the outputs of existing (non-learning-based) automated tools
such as Freesurfer and FSL-FIRST [16, 17]. Segmentation of deep-white matter
structures is highly relevant in multiple sclerosis, since a recent study of 1,417
MS patients has shown links between deep grey matter volume loss and wors-
ening condition in multiple sclerosis.[18]. In that study, segmentation of the
grey-matter structures was not carried out directly, since the tool used (FSL-
FIRST) is known to be biased by the presence of white-matter lesions. Instead,
the white-matter lesions were first identified using a freely available tool [19]
and removed from the imaging using ’lesion filling’, after which segmentations
of the relevant structures were prepared.
In this paper, we propose a new deep learning method performing a simul-
taneous segmentation of both lesions and grey-matter structures, trained on a
combination of lesion segmentations produced by expert raters, and weak la-
bels for the healthy-appearing tissue provided by an existing automated method
(Freesurfer). We hypothesize that the segmentation of these additional struc-
tures together with lesions does not negatively, and may in fact positively, im-
pact the quality of the lesion segmentation.
2. Methods
2.1. Study design and overview
We analyzed 122 fully anonymized MRI datasets of patients with remitting-
relapsing multiple sclerosis that were identified from the MS cohort databank
of the MS cohort of the University of Bern. Ethical approval for the study was
granted by the local ethical commission (Cantonal Ethical Commission Bern,
’MS segmentation disease monitoring’, approval number 2016-02035). For di-
rect comparison with other centers, we included a second dataset of ten fully
anonymized MRI datasets from the Radiology Center Bethanien/ZH. All pa-
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tients included in this dataset had provided a general consent for data storage
and analysis of their MRI datasets (CW).
2.2. Patient cohorts and MR imaging
Two cohorts of retrospective data were included in the analysis: 90 datasets
were included in the Insel90 dataset (used for training and validation of the clas-
sifier), and 32 patients were included in the Insel32 dataset (used in this paper
for testing the classifier). All datasets stemmed from patients who fulfilled the
diagnostic criteria (revised McDonald criteria of 2010) for relapsing-remitting
multiple sclerosis. [20] Datasets from the Inselspital were acquired using a stan-
dardized acquisition protocol on a 3T MRI (Siemens Verio, Siemens, Erlangen,
Germany) following the Revised Recommendations of the Consortium of MS
Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines
for the Diagnosis and Follow-Up of Multiple Sclerosis.[3] The protocol settings
included i) T1-weighted MDEFT pre- and post gadobutrol i.v. (Repetition time
TR = 7.92 ms, echo time TE = 2.48 ms, flip angle = 16, inversion with sym-
metric timing (inversion time 910 ms), 256 224 x 176 matrix points with a field
of view (FOV) of 256 mm 224 mm yielding a nominal isotropic resolution of 1
mm3, with fat saturation), ii) T2- weighted imaging (TR 6580 ms, TE 85 ms,
averages 2, FoV read 220 mm, FoV phase 87.5 %, voxel size 0.7 x 0.4 x 3.0 mm,
flip angle 150, acquisition time 6:03 min, 42 parallel images were acquired with
a slice thickness of 3.0 mm, iii) 3D FLAIR imaging (TR 5000 ms, TE 395 ms,
averages 1, FoV read 250 mm, FoV phase 100 %, voxel size 1.0 x 1.0 x 1.0 mm,
acquisition time 6:27 min. A total of 176 parallel images were acquired with
a slice thickness of 1.0 mm). All patients received Gadobutrol (Gadovist) 0.1
ml kg1 bodyweight immediately after the acquisition of the unenhanced T1w
sequence.
Anonymized training data from patients who had given informed consent was
taken for testing from a second centre. ( Radiology Center Bethanien) Datasets
were acquired on a 3T MRI (Siemens Skyra, Siemens, Erlangen, Germany).
i) T1-weighted MPRAGE precontrast (TR 2300 ms, TE 2.9 ms, TI 900 ms,
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averages 1, FoV read 250 mm, FoV phase 93.75 % voxel size 1.0 x 1.0 x 1.0
mm, flip angle 9, acquisition time 05:12 min. 176 slices per slab, slice thickness
of 1.0 mm) ii) T2- weighted imaging (TR 4790 ms, TE 100 ms, averages 1,
FoV read 220 mm, FoV phase 100 %, voxel size 0.7 x 0.4 x 3.0 mm, flip angle
150, acquisition time 02:16 min, 45 parallel images were acquired with a slice
thickness of 3.0 mm, iii) 3D FLAIR imaging (TR 5000 ms, TE 398 ms, TI 1800
ms, averages 1, FoV read 250 mm, FoV phase 100 %, voxel size 1.0 x 1.0 x 1.0
mm, flip angle 120, acquisition time 04:17 min. A total of 176 slices per slab
were acquired with a slice thickness of 1.0 mm).
This dataset from Zurich, together with training data from the MSSEG chal-
lenge [14] was used to assess centre- and scanner-independence. The datasets
belonging to the MSSEG challenge conform to the OFSEP guidelines, which
ensures a 3D FLAIR acquisition and a 3D T1 acquisition: we consider this a
minimum for high-quality multiple sclerosis imaging [21]. Briefly, 15 datasets
were obtained from three different centres in France, each using a different scan-
ner (Siemens Verio 3T, Siemens Aera 1.5T, and Philips Ingenia 3T). The images
were annotated by seven trained junior experts: their segmentations were fused
to provide a single ground-truth for training purposes (the 38 similar cases used
for the testing phase of the MSSEG competition were not available at the time
this manuscript was prepared).
2.3. Manual segmentation
MS lesion annotation of the Insel90 and Insel32 datasets was conducted by
two of the authors (RWe/FA), under the supervision of an experienced neuro-
radiologist with more than 15 years experience in MS reading (RWi). Manual
segmentation labels of the MS lesions were acquired through slice-by-slice anal-
ysis of all four sequences. The 3DSlicer platform [22] was used to perform the
manual lesion segmentation following the protocol in [23]. Lesions were identi-
fied if appearing hyper-intense compared to the surrounding normal-appearing
WM on T2w and FLAIR images, and slightly- to severely hypo-intense on T1-
weighted images. One of the authors (RWe) annotated the severely T1 hypo-
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intense ’black holes’ as an additional label.
As has previously been reported, inter-rater error for manual segmentation
of multiple sclerosis lesions is very high. For this reason, a further segmentation
of the cases was made by one of the authors (RM), supervised by an experienced
neuroradiologist with more than 10 years of experience (FW) who had access to
the initial segmentations. In this way, both false negative identifications (missed
lesions) and false positive identifications (healthy appearing tissue marked as
lesion) could be omitted . This multi-reader ’consensus’ segmentation between
three raters was used for training and validation of the classifier.
The Zu¨rich10 dataset was labelled bya Neuroradiologist with 9 years of ex-
perience (CW), following same segmentation protocol. [23].
2.4. Weak label generation using Freesurfer
Segmentations of the cortical grey matter,cortical white matter, ventricles,
cerebellum, thalamus, caudate, putamen, pallidum, hippocampus, amygdala,
brain stem, ventral DC, choroid plexus, corpus callosum and accumbens area,
were extracted from the volumetric segmentation (aseg.mgz) generated by ap-
plying Freesurfer 5.3 to the MDEFT acquisition. No label distinction was made
between left and right hemispheres. In addition to these healthy-appearing
tissue labels, Freesurfer also generated labels for white-matter hypointensities,
which encompass not only lesions due to multiple sclerosis, but also the ’caps
and ’bands’: age-related physiological changes in the periventricular regions
(mild ependymal loss, subependymal gliosis and widened extracellular space.
2.5. Baseline methods: Nabla-Net and SPM Lesion Segmentation Toolbox
As a baseline CNN-based MS lesion segmentation algorithm we use Nabla-
net [12]. Nabla-net was the winning lesion segmentation algorithm in the 2016
MSSEG challenge at MICCAI: on the unseen testing data of the challenge the
method achieved a mean Dice coefficient of 0.59. An important component of
the challenge was to assess performance on out-of-sample data: fifteen training
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examples were provided from three different centres, each using a different scan-
ner/sequence parameters. Testing data was also taken from those three centres,
together with data from a fourth centre/scanner which was unseen during train-
ing: also on this unseen centre, Nabla-net was the best-performing method.[14]1
As an additional, freely available baseline, we applied the two lesion segmen-
tation methods available in the Lesion Segmentation Toolbox (LST, available
at https://www.applied-statistics.de/lst.html).[19] The toolbox is inte-
grated into SPM, and provides two segmentation algorithms: a lesion prediction
algorithm (LPA), operating on FLAIR imaging alone, and a lesion growth al-
gorithm (LGA), operating on FLAIR and T1 imaging. As recommended by the
authors of the toolkit, we used our training cases to determine the best initial
threshold for the LGA algorithm.
2.6. The DeepSCAN architecture
For the classification of lesions and healthy appearing tissue, we use a cascade
of two convolutional neural networks (CNNs).
In a first step, a convolutional neural network is used to individually skull-
strip the T1, T2 and FLAIR images in their native spaces. Subsequently, the
skull-stripped T1 and T2 images are registered to the FLAIR space using a
rigid transformation (FSL-FIRST, 6 degrees of freedom, mutual information
cost function, spline interpolation) and resampled to 1mm3 resolution: a second
convolutional network is then applied to this multi-modal data to generate the
final segmentation. We used a two-stage approach to provide more robustness
against differences in the appearance of non-brain tissue (caused, for example,
by the use of a head-only coil vs. a head-and-neck coil).
The two CNNs used in this paper both follow the DeepSCAN architecture
introduced in [24]. A DeepSCAN network consists of initial 3D convolution
layers, then a U-net style encoder/decoder network [25] with a dense block
1For a detailed breakdown of the results for individual methods, see the supplementary
material to Commowick et. al [14]: https://zenodo.org/record/1307653
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[26] of dilated convolutions at the bottleneck. The shape of a network of this
architecture can therefore be specified by:
• The number of initial 3D convolutions
• The depth of the encoder/decoder (i.e. the number of downsampling steps)
• The topology of the dense block: how many dense units, and at what
dilation.
We describe in detail the used network topologies for skull-stripping and
segmentation in the appendix.
2.7. CNN for Brain extraction
Brain masks were prepared for the 122 T1-weighted MRIs in our training and
test dataset, using FSL-BET with hand-tuned parameters. These brain masks
were then transferred to the T2 and FLAIR images using rigid registration by
FSL-FLIRT. Brain images (T1, T2 and FLAIR) were standardized as follows:
• Calculation of 1st and 99th percentile of voxels with non-zero intensity,
and clipping of images to those intensities.
• Standardisation: calculation of mean and standard deviation of voxels
with non-zero intensity: subtraction of mean and division by standard
deviation across all voxels.
We then trained a DeepSCAN network to predict the BET brain-mask of an
axial, sagittal or coronal slice from T1, T2 or FLAIR imaging. The network
used had no 3D convolutions, a depth of 3 and had two dense units with dilation
1 and two dense units with dilation 2.
2.8. CNN for segmentation
The input data to the segmentation algorithm consists acquisitions of of
T1-weighted, T2 and FLAIR sequences. Before learning or prediction, these
volumes are minimally pre-processed as follows:
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• Skull-stripping of the FLAIR, T1 and T2 imaging, using the above-described
network, and cropping to remove empty voxels.
• Rigid registration of the skull-stripped T1 and T2 images to the skull-
stripped FLAIR image, using FSL-FLIRT, and resampling to 1mm isovox-
els.
• Calculation of 1st and 99th percentile of brain-tissue intensities (within
brain mask), and clipping of images to those intensities.
• Standardisation: calculation of mean and standard deviation of voxels
within brain mask: subtraction of mean and division by standard deviation
across all voxels.
In particular, no bias field correction was made to the input images, as it has
been shown to adversely affect the appearance of images with large white-matter
lesion load. [27]
We generated a segmentation label map for training by registering the Freesurfer-
derived segmentation to the 1mm isovoxel resampled FLAIR volume (using
the previously calculated rigid transformation, nearest neighbour interpolation),
and overlaying the lesion maps provided by the third ’consensus’ segmentation,
and the T1-hypointense ’black-hole’ maps, onto the weak tissue labels provided
by Freesurfer. This results in a ”ground truth” consisting of eighteen tissue
maps, each of which will be predicted by the classifier, plus a nineteenth ’back-
ground’ class, representing voxels not lying in any of the tissue classes in the
label map.
We trained a DeepSCAN network with two 3D convolutions, a depth of 1 and
24 dense units (6 each at dilation levels 1,2,4 and 8). We utilized the following
hybrid loss function:
1. For each target tissue class, a focal loss term with γ equal to 2. [28]
2. For each target tissue class, a focal label-flip loss term with γ equal to 2
[29]
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3. A multi-class focal loss term, where the logit of the background class is
set to 0.
The purpose of using focal loss (rather than ordinary binary or categori-
cal cross-entropy loss function) is to improve performance on tasks with a very
small ratio of voxels in the tissue class to voxels in the background class. The
focal label-flip loss, in which the classifier estimates the probability of misclas-
sification for each voxel and tissue class, has previously been shown to improve
convergence of networks used for brain segmentation. [29] In addition, the uncer-
tainty estimates themselves are used in a companion paper to identify patients
with lesion growth in longitudinal imaging. [30] Definitions of the loss functions
used in this paper are reproduced in the appendices.
The raw classifier output is an 18-element vector (x1, . . . , x18), for each voxel
in the volume, in which each element xi of the vector represents the log-odds
(or logit) of the given volume element being in one of the 18 tissue classes.
Tissue ”probabilities” (i.e. a number between zero and one) can be obtained
from the log-odds by applying the logistic function. During training a joint
loss function was minimized, consisting of the sum of the binary cross-entropies
for each tissue class separately, together with the softmax loss of the vector
(0, x1, . . . , x18), where the initial zero represents the logit of the background
class. As a result of this hybrid loss function, the classifier can be used in
two distinct ways for segmenting a given tissue class. Firstly, we may obtain
segmentations of each tissue class individually, by thresholding the logit maps:
DeepSCAN multi-task: a voxel is labelled as being in tissue class i if xi
is greater than zero (corresponding to a probability greater than 0.5).
In this mode, each segmentation task is treated separately (one-vs-all seg-
mentation). It is therefore possible that a given voxel may be assigned more
than one tissue class (i.e. xi and xj may both be greater than zero for distinct
i and j). This may occur due to partial volume effects, conflicting information
from the multimodal data, or input data outside of the parameters given by the
training data.
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If exactly one label is desired for each voxel, we may simply take the strongest
signal among the xi:
DeepSCAN softmax: a voxel is labelled as being in tissue class i if xi is
the greatest among (0, x1, . . . , x18).
Note that this approach differs from the traditional softmax, in that the
empty tissue label is assigned a default value of 0. This ensures that if none of
the tissue classes is well predicted, the classifier returns an empty label.
Training of the classifier was performed using the ADAM optimizer, with
a cosine-annealing learning rate schedule applied over each epoch [31]. The
batch size was two, with each 4*5*192*192 block being randomly sampled in
either an axial, coronal or sagittal direction from one of the training examples.
The classifier was trained on 50 cases taken from the Insel90 dataset, with the
remaining 40 cases being used to validate performance of the classifier during
training. The classifier was trained for 50 epochs without the label-uncertainty
loss, and for another 50 with the label-uncertainty loss.
When applied to a new case, the classifier is applied in the axial, coronal
and sagittal direction. Ensembling of these three outputs is then performed by
averaging the logits.
In order to test whether the inclusion of the additional tissue classes had
an effect on lesion segmentation, we also trained a version of the DeepSCAN
classifier with the same architecture but only two tissue classes (lesion and black
hole). We refer to this below as DeepSCAN (just lesions).
2.9. Identification of irreversible axonal damage: by segmentation vs by inten-
sity
Lesions which equal the signal intensity of CSF on T1w images are referred
to as ’black holes’. These areas resemble areas of axonal damage. Since a black-
hole label was provided during training the DeepSCAN model, this model can
be used to identify such lesions. We also propose a complementary method for
identifying black-holes. The mean and standard deviation of the T1-weighted
image intensity in the ventricles was calculated, and a value of the mean plus
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two standard deviations was defined as a cutoff for CSF-isointense tissue. All
tissue annotated by the classifier as lesion tissue, and also CSF-isointense, was
labelled as black hole.
2.10. Testing
Testing of the new lesion segmentation methods (DeepSCAN lesion only,
DeepSCAN multi-task and DeepSCAN softmax) and the baseline methods (Nabla-
net, and two methods from the Lesion Segmentation Toolkit (LST)) was per-
formed against the consensus manual segmentation on the Insel32 dataset by
three methods: Dice coefficient, lesion detection and volume difference.
In addition, we evaluated our proposed methods on the MSSEG training
data and the ZH10 data, to establish performance on data from different centres,
scanners and field strengths.
2.10.1. Dice coefficient
The Dice coefficient, also known as the Dice-Sørenson coefficient or Dice
Similarity score, is a standard measure of segmentation agreement. If X and Y
are two sets, the Dice coefficient is defined as
Dice(X,Y ) =
2|X ∩ Y |
|X|+ |Y | (1)
We calculated, for each testing case and each segmentation method, the
Dice coefficient between the lesion segmentation and the consensus segmenta-
tion. We also calculated the Dice coefficient between the individual raters, and
between each individual rater and the consensus lesion segmentation, to give
an impression of the inter-rater error. Dice coefficient was also used to rate
the quality of secondary segmentation targets. We compared three methods of
identifying T1 black holes: the black hole label supplied by DeepSCAN multi-
task, the black hole label supplied by DeepSCAN softmax, and the black hole
label supplied by identifying CSF-isointense areas in the DeepSCAN multi-task
FLAIR lesions, using Dice coefficient relative to the single manual rater. While
the main purpose of the weak labels for neuroanatomical structures is to re-
duce levels of false positive lesion identification in healthy-appearing tissue, we
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also report Dice coefficient between our algorithm and three existing automated
approaches: Freesurfer 5.3 (the source of the weak labels), Freesurfer 6.0 and
FSL-FIRST.
2.10.2. Lesion detection rates
In addition to assessing the quality of voxel-by-voxel detection of lesion tis-
sue, we also assess detection at the lesion level. We follow the proposed lesion
detection metrics of the MSSEG 2016 challenge, for reference see Commowick
et al. [14].
A ”lesion” in a given segmentation will be defined as a connected component
of the segmentation (with 18-connectivity kernel) of size 3mm3 or greater. We
use the notation DX(Y ) to stand for the detection rate of X-lesions in the
segmentation Y , meaning the proportion of lesions in X successfully detected
by Y . For these purposes, a lesion in X is detected by Y if:
• The lesion overlaps with lesions in Y by at least α%.
• The lesions which contribute most to the detection of the lesion (those
summing up to γ% of the overlap) do not lie more than β% outside the
lesion.
A lesion can thus fail to be detected either by ”undersegmenting” (the lesion
is missed, or is detected but the corresponding lesions in Y are too small), or by
”oversegmenting” (the corresponding lesions in Y are too large). We adopt the
values α = 10, β = 70, γ = 65 from [14]. The value DX(Y ) is then simply the
ratio of the number of lesions detected to the total number of lesions in X. If X
is the ”ground truth” and Y is any other segmentation , then DX(Y ) measures
the proportion of true lesions which were correctly segmented, or sensitivity, of
the segmentation Y . In this case, DY (X) is the proportion of lesions segmented
by Y which are in ”true lesions”, i.e. the precision or Positive Predictive Value.
2.10.3. Analysis of False Positives and False negatives
Since manual annotation of MS lesions is at risk of large inter-rater vari-
ability, we hypothesize that for a robust classifier differences between classifier
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output and manual annotations are more likely errors in the manual annota-
tion, than errors of the classifier.[8] To assess the extent to which this is true,
two raters (FW and LG) made a final assessment of each false positive lesion
(i.e. labelled by the algorithm but not overlapping the ground truth by more
than 10%), and each false negative lesion (i.e. labelled in the ground truth but
not overlapping with the segmentation of the algorithm by more than 10%).
The raters were blind to whether the lesion segmentation came from the man-
ual raters or the algorithm. The goal was to identify what proportion of ’false
positive’ lesions were in fact missed by all three raters, and what proportion of
’false negative’ lesions were in fact mislabelled (i.e. were normal-appearing grey
matter, choroid plexus, or the result imaging artifacts).
2.10.4. Lesion Volumetry
Finally, we assessed lesion volumetry, both by correlation and Bland-Altman
analysis. For comparison, we provide the performance also for our previous
lesion-segmentation method, Nabla-Net.
3. Results
3.1. Lesion segmentation on the Insel32 dataset
3.1.1. Dice coefficient
The mean Dice coefficient between the two individual raters was 0.58 (stan-
dard deviation 0.17), while the mean Dice coefficient between the raters and the
human-derived consensus was 0.63 (s.d. 0.12) and 0.57 (s.d. 0.20) respectively.
The mean Dice coefficient of lesion segmentation derived from DeepSCAN
against the human-derived consensus was 0.57 (s.d. 0.16) when segmenting le-
sions only, 0.60 (s.d. 0.12) when using multi-task classification, and 0.59 (s.d.
0.14) when using softmax classification. For comparison, the mean Dice coe-
ficient of lesion segmentation derived from our previous algorithm (Nabla-net)
against the human-derived consensus was 0.49 (s.d. 0.19). Box plots of the
distribution of Dice scores can be seen in Figure 4, together with performance
of LGA and LPA.
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Figure 1: Example segmentations of a case from the Insel32 dataset, sagittal view. (A) FLAIR
image, plus segmentations from (B) manual raters, (C) LPA, (D) LGA, (E) Nabla-net and
(F) DeepSCAN (multi-task)
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Figure 2: Example segmentations of a case from the Insel32 dataset, axial view. (A) FLAIR
image, plus segmentations from (B) manual raters, (C) LPA, (D) LGA, (E) Nabla-net and
(F) DeepSCAN (multi-task). Segmentations from LGA and LPA show erroneous segmenta-
tion of healthy-appearing tissue near the ventricles (cyan arrows). DeepSCAN identified two
subtle lesions (violet arrows) missed by the manual raters but subsequently confirmed by our
experienced neuroradiologists.
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Figure 3: A sagittal slice from a case in the Insel32 dataset. Top left, FLAIR, Top right, T1
MDEFT, bottom left, fused ’ground truth’, bottom right, DeepSCAN softmax output. Labels
derived from the DeepSCAN tool are smoother and more anatomically plausible than those
derived from Freesurfer.
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Figure 4: Boxplots showing Dice coefficients of the lesion segmentation on the Insel32 dataset.
Significance levels refer to Wilcoxon signed Rank tests. Not shown: Nabla-net vs Consensus
is significantly different to Rater 1 vs Rater 2, Rater 1 vs Consensus, and Rater 2 vs Consen-
sus. LPA vs consensus is significantly worse than all shown methods. LGA vs consensus is
significantly worse than all shown methods except LPA.
Wilcoxon signed rank tests show that the Dice coefficients between the hu-
man consensus and Nabla-net are significantly different to those between Deep-
SCAN (multi-task) and the human consensus (p < 1e−5) and to those between
DeepSCAN (softmax) and the human consensus (p < 1e− 5). In terms of Dice
coefficient comparisons with the human consensus, no significant difference was
found between the three segmentations of DeepSCAN (lesion only, multi-task
and softmax), or between the segmentations of DeepSCAN and the individual
human raters.
3.1.2. Lesion detection
Over all 32 test subjects in the Insel32 dataset, there were a total of 2701
lesions annotated in the consensus labelling. Of those lesions, 509 were suc-
cessfully detected by Nabla-net, 1333 by DeepSCAN (softmax) and 1355 by
DeepSCAN (multi-task). Nabla-net annotated 1153 structures as being lesions,
of which 385 were present in the consensus labeling. DeepSCAN (softmax) an-
notated 1927 structures as lesions, of which 1204 were present in the consensus
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labelling. 2019 lesions structures were annotated by DeepSCAN (multi-task) as
lesions, of which 1366 were present in the consensus labeling.
In summary, over the Insel32 dataset, Nabla-net had a sensitivity of 0.19,
and a precision of 0.34, DeepSCAN (softmax) had a sensitivity of 0.49 and a
precision of 0.62, and DeepSCAN (multi-task) had a sensitivity of 0.50 and a
precision of 0.68. The distributions of per-patient sensitivity, precision and F1
score are displayed by the boxplots in Figure 5, together with performance of
LGA and LPA.
All three segmentations offered by the DeepSCAN had F1 scores, sensitivity
and precision superior that offered by Nabla-net (Wilcoxon signed rank test,
p < 1e − 6). Between the DeepSCAN segmentations, the multi-task segmen-
tation had significantly better precision (p = 0.003) and F1 score (p=0.0008)
than the softmax segmentation, but the two did not have significantly different
sensitivities (p= 0.014). DeepSCAN (multitask) also had significantly better F1
(p=0.003) and sensitivity (p=0.0006) than DeepSCAN (just lesions).
3.1.3. Restrospective classification of false positives/negatives
Of the 2701 lesions in the consensus ground truth, the multi-task classifier
failed to find 777 (a further 569 were oversegmented). However, in the ret-
rospective lesion analysis, 579 out of those 777 (75%) were judged by a pair
of trained neuroradiologists working together as being mislabelled (i.e. were
normal-appearing grey matter, choroid plexus, or the result imaging artifacts).
Of the 2019 lesions annotated by DeepSCAN multi-task, 372 did not overlap
more than 10% with lesions in the consensus ground truth. In the retrospective
lesion analysis, 137 of those lesions (37%) were judged to be genuine lesions
which had been missed by the manual raters. Among those missed lesions were
several subtle cortical lesions, such as the one depicted in Figure 6.
3.1.4. Detection/segmentation of T1 hypointense ‘black holes’
Boxplots of the Dice coefficient over the Insel32 dataset for black hole seg-
mentation are shown in Figure 7. Wilcoxon signed rank tests showed no signif-
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Figure 5: Boxplots showing lesion detection metrics on the Insel32 dataset. Significance levels
refer to Wilcoxon Signed Rank test. Not shown: in all plots, LGA, LPA and Nabla-net are
significantly worse than the three DeepSCAN methods (p < 10−6).
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Figure 6: Example of a subtle cortical lesion from the Insel32 dataset found by DeepSCAN
but missed by all raters. (A) FLAIR image: no lesions were annotated by any raters on this
slice, but cortical region indicated is hyperintense (B) coregistered skull-stripped T1 image of
the same slice, showing T1 hypointensity in the location of suspect lesion. (C) Segmentation
friom DeepSCAN, correctly identifying the missing cortical lesion.
icant difference between DeepSCAN binary and the T1w-intensity method for
identifying Black holes, while both of those methods were significantly better
than DeepSCAN softmax.
3.2. Segmentation of healthy-appearing grey matter structures on the Insel32
dataset
An example of the whole-brain segmentation generated by DeepSCAN Soft-
max can be seen in Figure 3, and boxplots of the Dice coefficient for the
segmentation (DeepSCAN multi-task) of various grey-matter structures, when
compared with three freely available tools (FSL-FIRST, Freesurfer 5.3, and
Freesurfer 6.0) can be found in Figure 8. In two cases (Putamen and Pallidum),
the Dice coefficents between DeepSCAN and Freesurfer 5.3 (which supplied the
training data) were significantly better than those with Freesurfer 6.0 and FSL-
FIRST. In the other five cases, at least one of FSL-FIRST or Freesurfer 6.0
compared better with the output of DeepSCAN than Freesurfer 5.3. In gen-
eral, as can be seen in Figure 3, the boundaries of the structures segmented
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Figure 7: Distribution of the Dice Coefficients for T1 black hole segmentation, .
by DeepSCAN are smoother and more anatomically plausible that those gener-
ated by Freesurfer. Mean Dice coefficient for each structure, and each reference
method, exceeded the Dice coefficient for lesion segmentation, suggesting that
strong spatial priors make these structures easier to segment.
3.3. Testing of Centre/Scanner robustness
We applied our newly developed lesion segmentation algorithm to smaller
datasets from different centres, and on different scanners, to evaluate the ro-
bustness of our method to new out-of-sample data.
3.3.1. MSSEG Challenge Training data
For each of the fifteen training cases of the MSSEG challenge, the organizers
provided seven manual segmentations, plus a consensus segmentation. Our
reference method, Nabla-net, was trained on these fifteen cases, so we refer in
this section to the cross-validated performance of Nabla-net (train on ten cases,
test on the remaining five).
Mean Dice coefficients versus the fused ground-truth for DeepSCAN multi-
task, DeepSCAN softmax and Nabla-net were 0.66, 0.66 and 0.67 respectively.
Mean F1 lesion detection scores were 0.55, 0.55 and 0.49 respectively. Wilcoxon
23
Figure 8: Boxplots of Dice coefficients for various automatic segmentations of grey-matter
structures. Significance levels refer to Wilcoxon signed rank tests between FS5 vs DeepSCAN
and the other automated methods.
signed rank tests showed no significant difference between the three methods on
either score, meaning that the DeepSCAN methods, trained on out-of-sample,
performed as well as Nabla-net trained on data from the same distruvution as
the test data.
Versus the independent MSSEG raters, mean agreement ranged between 0.56
and 0.61 for both DeepSCAN multitask and DeepSCAN softmax, and between
0.55 and 0.62 for Nabla-net. For comparison, the mean Dice coefficient between
the MSSEG raters on the training data ranged between 0.54 and 0.75: in other
words, both Nabla-net and DeepSCAN performed within the inter-rater range
of performance, when measuring Dice coefficients.
3.3.2. Zurich10 dataset
Mean Dice coefficient for DeepSCAN multi-task on this dataset was 0.51, and
mean Dice coefficient for DeepSCAN Softmax was 0.52. Mean lesion detection
F1 for DeepSCAN multi-task on this dataset was 0.48, and mean lesion detection
F1 for DeepSCAN softmax was 0.48. Wilcoxon signed rank tests found no
difference between the two methods on this dataset.
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3.4. Lesion volumetry
Bland-Altman plots of DeepSCAN (multi-task) and DeepSCAN (softmax)
for the task of lesion segmentation, compared with the consensus segmentation,
across all three test datasets (Insel32, Zurich10 and MSSEGG) are shown in
Figure 9. The softmax segmentation showed no trend with increasing volume,
and little bias, while the multi-task network showed a bias towards larger lesion
load than the human raters, and a statistically significant (p = 2e− 5) trend.
4. Discussion
We proposed a new classifier for MS lesion segmentation, in which lesion
segmentation performance is improved by simultaneous labelling of healthy-
appearing structures, reducing the number of false positive and false negative
identifications. We demonstrated substantial improvements in lesion-wise false
positive and false negative rates over existing methods, and robustness across
vendors and centres.
We compared the performance of our proposed method with an award-
winning lesion segmentation algorithm from a recent segmentation challenge.[14]
When compared with the cross-validated performance of the reference method
trained the multi-centre training set from that challenge (MSSEG), no signif-
icant difference in results was found between DeepSCAN and Nabla-net, the
best performing method in terms of Dice coefficient on the 2016 MSSEG test-
ing set, suggesting that adequate performance on multi-centre/scanner data can
be derived from training on single-centre data. When applied to held-out test
data from our institution, the proposed method performed significantly better
than the reference method, in terms of Dice coefficient, sensitivity, and precision
of lesion segmentation. In particular, lesion-wise sensitivity, precision and F1
score scores for the proposed method were twice those of the baseline. Perfor-
mance was similar on data coming from a second centre in Switzerland, and
performance on the training data from the MSSEG challenge was similar to the
performance of an award-winning baseline method trained on in-sample data:
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Figure 9: Bland-Altman plots comparing automated and human lesion volumetry on the
Insel32, MSSEG and Zurich datasets. Trendline shown in red for each case. The softmax
segmentation showed no significant trend in volumetric difference (p=0.22), while the multi-
task segmentation showed a significant positive trend (slope = 0.2, p=2e-5)
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we did not see the reduction in performance on out-of-sample data reported for
other methods.
The method also provides segmentations, and so volumetry, of cortical grey
matter and deep grey matter structures. Segmentation quality, when measured
by Dice coefficient, did not show a bias towards the training data: while the au-
tomated labelling was generated from Freesurfer 5.3, agreement with Freesurfer
5.3 was lower than with Freesurfer 6 in 5 out of seven structures examined, and
was lower than agreement with FSL FIRST in three out of seven structures
examined. This suggests that the classifier is not merely reproducing the seg-
mentation of Freesurfer 5.3. One obvious exception to this trend is Putamen
segmentation, where the method agreed substantially more with Freesurfer 5.3
than with the other two methods. This can, perhaps, be explained by a known
issue with Freesurfer 5.3, where the segmentation of the putamen intrudes into
the claustrum: this also led to low agreement between Freesurfer 5.3 and human
raters. [32].
Current assessments of segmentation algorithm quality rely on comparison
either with single human raters or consensus segmentations derived from mul-
tiple raters. Typically, consensus segmentations are preferred because of the
high inter-rater variability of MS lesion segmentation: on the MSSEG training
dataset, for example, mean Dice coefficients between the independent expert
raters ranges between 0.75 and 0.54. Meanwhile the agreement between Deep-
SCAN and the individual MSSEG raters was between 0.57 and 0.61, showing
that our performance is within the range of human inter-rater variability. Per-
formance on the MSSEG training dataset, which was not used for training our
classifier, was not significantly worse than the cross-validated performance of
Nabla-net. Performance on an additional external validation set was also sim-
ilar to the performance on our internal validation set, suggesting that domain
adaptation may be less crucial when applying our method to data from differ-
ent clinics. This contrasts to previously reported results, where performance on
data from previously unseen centres was substantially degraded without domain
adaptation [15].
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Our post-hoc examination of missed and oversegmented lesions showed that,
despite substantial efforts to produce a robust ground truth segmentation, 579
lesions (out of a total of 2701) in the test set were found to be mislabelled
healthy-appearing tissue. Meanwhile, of the 2019 lesions annotated by Deep-
SCAN multitask, 137 were judged to be missed lesions (i.e. genuine lesions
not present in the ground truth), and only 235 were judged to be mislabelled
healthy-appearing tissue. While we can not guarantee that this method has
found all false positive identifications of lesions in the segmentations, this cor-
responds to a roughly 11% rate of false positives for DeepSCAN, vs a 21% false
positive rate for the consensus of manual raters. The fact false positive rates
among a consensus of human raters is more than double that of an automated
classifier shows that comparisons with human raters may, in the end, be insuffi-
cient to judge whether systems such as the one we propose can be used in clinical
practice. Even in carefully curated lesion annotation datasets, the difficulty of
the lesion segmentation task was such that substantial numbers of lesions were
missed, and an even greater number of false positive lesion identifications were
made in the ’ground truth’. In the end, these systems must be validated inde-
pendently of comparing to human raters, as a biomarker for disease progression.
Nonetheless, our results show that it is possible to train classifiers even on such
noisy ground truths. In a companion paper, we show that by using measures of
uncertainty derived from the loss function of our classifier, we can distinguish
between stable and progressive timepoints in relapsing-remitting MS.
While clinical practice is shifting towards low threshold treatment change
if a single new, clinically silent T2 lesion is detected, most routine investiga-
tions still omit grey matter atrophy as an early and reproducible feature of
MS. Several studies consistently demonstrated a link between atrophy, disease
progression and cognitive dysfunction, yielding differences between different MS
phenotypes. Grey matter atrophy is present from the earliest stages of multiple
sclerosis, spreading consistently across multiple sclerosis phenotypes and involv-
ing increasing numbers over time.[33] Covariance analysis of regional grey matter
atrophy may inform the determination of altered network topology among dif-
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ferent MS phenotypes. Such new network metrics depend on accurate and fast
region-wise volumetric measures and constitute an new class of biomarkers for
the neurodegenerative component of multiple sclerosis. While in this paper, we
do not address regional grey matter atrophy, segmentations of the cortical grey
matter are produced as one of the compartments segmented by our proposed
method. Together with registration to an atlas this method can therefore pro-
duce regional volumetric measures. Furthermore, by applying a method such as
DiReCT, measures of cortical thickness can be extracted from the tissue maps
produced by DeepSCAN.[34, 35].
As well as potential clinical impact, the tool we have developed has the po-
tential to improve other neuroimaging studies. For example, in order to measure
the volumes of subcortical structures of MS patients in a recent study, it was
necessary to first automatically segment the lesions, then perform lesion filling,
and finally segment the relevant structures. [18] By contrast, using our proposed
method the segmentations of subcortical structures could be derived directly:
alternatively, if established tools for the segmentation of subcortical structures
are preferred, our lesion segmentation provides a more complete identification
of the lesion load than previously available tools.
There are several limitations of the study which may be improved in sub-
sequent work. The major limitation is that the labels of healthy-appearing struc-
tures are derived from, and compared to, other automated tools (Freesurfer5.3/6.0
and FSL-FIRST). A more useful comparison would be between our automated
tool and manual expert labels. One could also expect that a tool trained on
better quality labels would perform better in such a comparison, and it would be
instructive to compare performance on of a classifier trained on small, human-
labelled datasets versus those trained on larger weakly labelled datasets, as well
as methods combining the two.
Another limitation of the current study is our attention only to cross-sectional
data. In a companion study [30], we propose to look at longitudinal imaging
of the same Insel32 dataset, in order to demonstrate the viability of automated
methods for reliably detecting changes in lesion loads. Improved labelling (weak
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or human-derived) of the healthy-appearing tissue, in particular the cortex,
would allow such methods to be applied also to atrophy biomarkers.
Finally, while we validated our methodology on a number of datasets, includ-
ing one publicly available challenge training dataset, we believe that the best
basis for the comparison of methods such as the one we propose is the provision
of challenges, in which methods are applied to hidden testing datasets indepen-
dently of the challenge participants. As an alternative, for groups unwilling or
unable to participate in challenges, it is essential that those groups who can
release their methods to provide a baseline for further development: we intend
to prepare the method presented in this paper for distribution for this purpose.
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Appendix A. Details of the DeepSCAN architecture and CNN train-
ing
Densenet [26] is a recently introduced architecture for image classification.
The fundamental unit of a Densenet architecture is the densely connected block,
or dense block. Such a block consists of a number of consecutive dense units, as
pictured in Figures A.11 and A.12 . In such a unit, the output of each convolu-
tional layer (where a layer here means some combination of convolutional filters,
non-linearities and batch normalization) is concatenated to its input before pass-
ing to the next layer. The goal behind Densenet is to build an architecture which
supports the training of very deep networks: the skip connections implicit in the
concatenation of filter maps between layers allows the flow of gradients directly
to those layers, providing an implicit deep supervision of those layers.
In the original Densenet architecture, which has state-of-the-art performance
on the CIFAR image recognition task, dense blocks are combined with transition
blocks: non-densely connected convolutional layers, followed by a maxpooling
layer. This helps to control parameter explosion (by limiting the size of the input
to each dense block), but also means that the deep supervision is not direct, at
the lowest layers of the network. This Dense-plus-transition architecture was
also adopted by Jegou et al. [36], whose Tiramisu network is a U-net-style
variation of the Densenet architecture designed for semantic segmentation.
In a previous paper on brain tumor segmentation [24], we proposed an al-
ternative hybrid of U-net [25] and Densenet, in which the bottleneck layer of
the Unet is a single dense block, and in which some or all of the pooling and
upscaling is replaced by dilated convolutions. Some kind of pooling is found in
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almost all CNNs for image classification. The principal reason to use pooling is
to efficiently increase the receptive field of the network at deeper levels without
exploding the parameter space, but another common justification of pooling,
and maxpooling in particular, is that it enables some translation invariance.
Translation invariance is of course undesirable in semantic segmentation prob-
lems, where what is needed is instead translation equivariance: a translated
input corresponding to a translated output. To that end, we use layers with di-
lated convolutions to aggregate features at multiple scales. Dilated convolutions,
sometimes called atrous convolutions, can be best visualized as convolutional
layers “with holes”: a 3 by 3 convolutional layer with dilation 2 is a 5 by 5
convolution, in which only the centre and corner values of the filter are nonzero,
as illustrated in Figure A.10. Dilated convolutions are a simple way to increase
the receptive field of a classifier without losing spatial information.
Figure A.10: Left, a 3 by 3 kernel. Right, a 3 by 3 kernel with dilation 2, visualized as a 5 by
5 kernel
The DeepSCAN network used to segment lesions and healthy-appearing
brain structures in this paper is shown in FigureA.11, while the network used
to for initial brain extraction is shown in Figure A.12.
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Figure A.11: The DeepSCAN architecture used in this paper for lesion and brain-structure
segmentation
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Figure A.12: The DeepSCAN architecture used in this paper for brain extraction
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Appendix B. Custom loss function
The loss function we use is an unweighted combination of three individual
loss functions: a focal loss function for each tissue class, a new uncertainty
aware loss term for each tissue class, which estimates the probability that the
predicted tissue class differs from the ground-truth label, and a slightly modified
softmax loss term over all tissue classes.
i) The focal loss function of [28] was developed for situations where there is
substantial class imbalance in classification problems: for MS lesions and also
many neuroanatomical tissue types this is the case. The loss function works by
reducing the contribution of already well-classified examples to the loss function,
and is given by
Focalγ(p, x) = (1− px)γ(BCE(p, x)) (B.1)
where BCE is the standard binary cross-entropy loss, p is the output probability
of the network, x is the label in the ground truth, and px = x∗p+(1−x)∗(1−p)
. For the purposes of this paper we set the value of γ to be 2.
ii) label-uncertainty loss is a new loss function for binary classification al-
lowing networks to quantify their own uncertainty. In brief, for each voxel, and
each segmentation subtask (whole tumor, tumor core, and enhancing tumor) the
network outputs two probabilities: the probability p that the label is positive,
and the probability q that the label predicted does not correspond to the label
in the ground-truth annotation (i.e., the probability of a ’label flip’). IF BCE
stands for the standard binary cross-entropy loss, and y is the target label, then
the label-uncertainty loss is:
BCE(p, (1− x) ∗ q + x ∗ (1− q)) +BCE(q, z) (B.2)
where
z = (p > 0.5) ∗ (1− x) + (p < 0.5) ∗ x (B.3)
If q is close to zero, and the label is correct, the first term is approximately
the ordinary BCE loss: if q is close to 0.5 (representing total uncertainty as to the
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correct label) the first term tends to zero. This loss therefore attenuates loss in
areas of high uncertainty (i.e., where the network is often incorrect), in a similar
fashion to the heteroscedastic loss of [37]. However, in [37] the uncertainty in the
classification is modeled by assuming that logits have a Gaussian distribution,
and estimating the variance of that Gaussian: this cannot be performed directly
by gradient descent, instead requiring Monte Carlo sampling of the Gaussian
distribution to perturb the output of the network. By contrast, label-uncertainty
can be incorporated directly into the loss-function of the network.
In practice, since not only the labels, but also the areas of label uncertainty
are in the minority we minimize the following loss function:
Focal2(p, (1− x) ∗ q + x ∗ (1− q)) + Focal2(q, z) (B.4)
iii) Multi-class classification (in which each element, here voxel, is assigned
exactly one label), is typically managed in deep learning using a Softmax non-
linearity and a categorical cross-entropy loss function. For the purposes of
classification the chosen class is the one with the largest output. Given outputs
y = y0, . . . , yn, the softmax nonlinearity returns
σ(y)j =
exp(yj)∑n
i=0 exp(yi)
(B.5)
Thus the outputs of the softmax are scaled such that they sum to one, and
can be regarded as probabilities.
In cases where we insist that a label is assigned to each example, this func-
tions well. However, it can be in a softmax that no label is predicted with high
confidence: in this case the most likely label is still predicted. To avoid that
this leads to erroneous/random classification of tissue as lesions we add a back-
ground class with a fixed output of 0 (corresponding to a probability of 0.5).
This ensures that only voxels predicted as being lesion (or any other class) by
multi-task classification will be assigned that class by softmax.
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